Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

317
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
317
Disorder of Water Balance01:29

Disorder of Water Balance

346
Water balance disorders are medical conditions that occur when there is a deviation from the body's water volume or osmolarity, disrupting normal homeostasis and leading todehydration, hypotonic hydration, hyperhydration, edema, or water intoxication.
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
346
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

177
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
177
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

478
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
478
Drug Therapy01:28

Drug Therapy

41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
41
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

665
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
665

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-Acute Sequelae of COVID-19 (PASC) in Hospitalized and Ambulatory Patients: A Comparative Study.

Journal of clinical medicine·2026
Same author

Kidney transplantation in Alport syndrome: A genotype-guided case series and literature review.

Turkish journal of surgery·2026
Same author

Living donor kidney transplantation in a patient with inherited skin fragility disorder in a resource-limited setting: a case report.

Journal of surgical case reports·2025
Same author

Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.

Clinical kidney journal·2024

Related Experiment Video

Updated: Jun 21, 2025

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

312

Hyponatraemia-treatment standard 2024.

Goce Spasovski1

  • 1Department of Nephrology, University of Skopje, Sts. Cyril and Methodius, Skopje, N. Macedonia.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|July 15, 2024
PubMed
Summary

Hyponatraemia, a common hospital disorder, requires careful correction. Symptomatic cases benefit from rapid hypertonic saline, while mild cases need fluid restriction and solute intake, with urea as a safe second-line SIADH therapy.

Keywords:
diureticsfluid restrictionhyponatremiaureavaptans

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.0K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.9K

Related Experiment Videos

Last Updated: Jun 21, 2025

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

312
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.0K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.9K

Area of Science:

  • Nephrology
  • Internal Medicine
  • Endocrinology

Background:

  • Hyponatraemia is the most frequent electrolyte disturbance in hospitalized patients.
  • It is linked to significant increases in morbidity, mortality, hospital stay duration, and healthcare costs.
  • The management of hyponatraemia necessitates careful consideration of symptom severity, duration, and biochemical parameters.

Purpose of the Study:

  • To review current therapeutic strategies for hyponatraemia, focusing on correction speed and specific patient populations.
  • To evaluate the efficacy and safety of different treatment modalities, including fluid restriction, hypertonic saline, urea, and vaptans.
  • To provide guidance on selecting appropriate second-line therapies for hypotonic hyponatraemia, particularly in Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH) patients.

Main Methods:

  • Review of existing literature and clinical guidelines on hyponatraemia management.
  • Analysis of treatment approaches based on symptom presentation (symptomatic vs. asymptomatic) and severity.
  • Evaluation of the role of fluid restriction, solute intake, hypertonic saline, urea, and vaptans in different hyponatraemic states.

Main Results:

  • Rapid intermittent administration of hypertonic saline is recommended for symptomatic hyponatraemia.
  • For asymptomatic mild hyponatraemia, fluid restriction (FR) and adequate solute intake are preferred initial strategies.
  • Urea and tolvaptan are effective second-line therapies for SIADH, with oral urea noted for its safety and efficacy.

Conclusions:

  • Gradual correction and clinical evaluation are emphasized over rapid normalization of serum sodium levels.
  • Close monitoring and preparedness for interventions like hypotonic fluids or desmopressin are crucial for optimal outcomes.
  • Further evidence is needed to guide the choice of second-line therapies for hypotonic hyponatraemia, especially in non-responders to initial FR for SIADH.